REG - ConvaTec Group PLC - Total Voting Rights

ConvaTecAnnouncement

01/11/2023 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231101:nRSA9425Ra&default-theme=true

RNS Number : 9425R  ConvaTec Group PLC  01 November 2023

01 November 2023

Convatec Group Plc

("Convatec" or "the Company")

Total Voting Rights

The following notification is made in accordance with the UK Financial Conduct
Authority's Disclosure and Transparency Rule 5.6.1. As at 31 October 2023, the
Company's issued capital with voting rights consisted of 2,049,789,559
ordinary shares of 10p each ("Shares"). The Company does not hold any Shares
in Treasury at the date of this disclosure.

The above figure (2,049,789,559) can be used by shareholders as the
denominator for the calculations by which to determine if they are required to
notify their interest in, or a change to, their interest in the Company under
the UK Financial Conduct Authority's Disclosure and Transparency Rules.

 

Enquiries

 

Ria Banerjee, Deputy Company Secretary
 
 
             +44(0)7425655845

 

Cosec@convatec.com

 

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

 

About Convatec

 

Pioneering trusted medical solutions to improve the lives we touch: Convatec
is a global medical products and technologies company, focused on solutions
for the management of chronic conditions, with leading positions in advanced
wound care, ostomy care, continence care and infusion care. With around 10,000
colleagues, we provide our products and services in almost 100 countries,
united by a promise to be forever caring. Our solutions provide a range of
benefits, from infection prevention and protection of at-risk skin, to
improved patient outcomes and reduced care costs. Group revenues in 2022 were
over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:
CTEC). To learn more about Convatec, please visit www.convatecgroup.com
(http://www.convatecgroup.com) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRKZMFGRMMGFZM